Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment

Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment

Background: Nasopharyngeal carcinoma (NPC) involves host genetics, environmental and viral factors. In clinical observations, patients of young and old ages were found to have higher recurrence and metastatic rates. Methods: Cytokine array was employed to screen druggable target(s). The candidate ta...

Full description

Bibliographic Details
Main Authors: Hsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui, Yin-Kai Chao, Chun-Nan Yeh, Li-Yu Lee, Yenlin Huang, Tung-Liang Lin, Yung-Chia Kuo, Mei-Yuan Huang, Yi-Ru Lai, Yuan-Ming Yeh, Hsien-Chi Fan, An-Chi Lin, Jason Chia-Hsun Hsieh, Kai-Ping Chang, Chien-Yu Lin, Hung-Ming Wang, Yu-Sun Chang, Cheng-Lung Hsu
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
NPC
PDX
EBV
EGF
EGFR blocker
CDK4/6 inhibitor
Online Access:https://www.mdpi.com/2072-6694/13/12/2954

Internet

https://www.mdpi.com/2072-6694/13/12/2954

Similar Items